LEALI, Daria
 Distribuzione geografica
Continente #
NA - Nord America 2.600
EU - Europa 1.510
AS - Asia 1.201
SA - Sud America 218
AF - Africa 47
OC - Oceania 5
Totale 5.581
Nazione #
US - Stati Uniti d'America 2.552
PL - Polonia 503
CN - Cina 434
SG - Singapore 361
DE - Germania 282
UA - Ucraina 208
BR - Brasile 182
HK - Hong Kong 121
GB - Regno Unito 105
VN - Vietnam 84
FI - Finlandia 82
RU - Federazione Russa 68
IT - Italia 65
FR - Francia 56
TR - Turchia 42
ES - Italia 37
IE - Irlanda 36
IN - India 34
CA - Canada 27
BD - Bangladesh 24
SE - Svezia 18
CZ - Repubblica Ceca 15
IR - Iran 15
JP - Giappone 13
ZA - Sudafrica 12
MX - Messico 11
AR - Argentina 9
ID - Indonesia 9
KR - Corea 7
MA - Marocco 7
PK - Pakistan 7
CO - Colombia 6
NO - Norvegia 6
EC - Ecuador 5
EG - Egitto 5
ET - Etiopia 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
AT - Austria 4
AU - Australia 4
CL - Cile 4
IL - Israele 4
LT - Lituania 4
MU - Mauritius 4
NG - Nigeria 4
NL - Olanda 4
PY - Paraguay 4
TH - Thailandia 4
VE - Venezuela 4
AZ - Azerbaigian 3
BE - Belgio 3
BG - Bulgaria 3
DZ - Algeria 3
GE - Georgia 3
IQ - Iraq 3
PH - Filippine 3
SK - Slovacchia (Repubblica Slovacca) 3
HN - Honduras 2
JO - Giordania 2
KG - Kirghizistan 2
LK - Sri Lanka 2
MY - Malesia 2
PA - Panama 2
RO - Romania 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
BZ - Belize 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GH - Ghana 1
GR - Grecia 1
GY - Guiana 1
HU - Ungheria 1
JM - Giamaica 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MK - Macedonia 1
MZ - Mozambico 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
UY - Uruguay 1
Totale 5.581
Città #
Warsaw 502
Fairfield 259
Ashburn 236
Woodbridge 192
Singapore 191
Jacksonville 158
Houston 155
San Jose 144
Ann Arbor 133
Hong Kong 114
Beijing 108
Wilmington 106
Seattle 105
Chandler 92
Cambridge 84
Los Angeles 64
Princeton 64
The Dalles 55
Helsinki 50
Nanjing 46
New York 39
Dearborn 38
Dublin 36
Dallas 33
Madrid 31
Lauterbourg 30
Istanbul 29
Jinan 27
San Francisco 25
Shanghai 24
Brescia 23
Santa Clara 23
Dong Ket 21
Council Bluffs 20
Porto Alegre 20
Ho Chi Minh City 19
Des Moines 18
Nanchang 18
Buffalo 17
Shenyang 16
São Paulo 16
Changsha 15
Hebei 14
Jiaxing 14
Orem 14
Brno 13
Chicago 13
Lancaster 13
Hanoi 12
Munich 12
Stockholm 12
Tokyo 12
Brooklyn 11
London 11
Redondo Beach 11
San Mateo 11
Hangzhou 10
Moscow 10
Phoenix 10
Johannesburg 9
Poplar 9
Rio de Janeiro 9
Chennai 8
Frankfurt am Main 8
Kunming 8
Milan 8
Montreal 8
Nuremberg 8
San Diego 8
Nürnberg 7
Jakarta 6
Kilburn 6
Oslo 6
Tehran 6
Tianjin 6
Verona 6
Atlanta 5
Bahir Dar 5
Biên Hòa 5
Campinas 5
Denver 5
Haikou 5
Ningbo 5
Uberlândia 5
Zhengzhou 5
Abuja 4
Ardabil 4
Augusta 4
Bangkok 4
Boardman 4
Glasgow 4
Kocaeli 4
Monmouth Junction 4
Paris 4
Santiago 4
Tashkent 4
Toronto 4
Ankara 3
Baku 3
Baliuag 3
Totale 3.827
Nome #
Long Pentraxin-3 inhibits FGF-dependent angiogenesis andgrowth of steroid hormone-regulated tumors 354
Nanoliter contact angle probes tumor angiogenic ligand-receptor protein interactions 305
Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived antiangiogenic pentapeptide. 301
Gremlin is a novel agonist of the major pro-angiogenic receptor VEGFR2 292
The pattern recognition receptor PTX3 as an angiostatic epithelial/stromal FGF-targeting inhibitor in hormonal cancers 248
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 226
Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist. 225
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 214
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 209
Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer. 206
Fibroblast growth factor-2 antagonist and Antiangiogenic activity of long-pentraxin 3-derived synthetic peptides 202
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells. 202
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumour cells. 177
Role of Nanomechanics in Canonical and Noncanonical Pro-angiogenic Ligand/VEGF Receptor-2 Activation 176
Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity 148
Isolation and characterization of a neutralizing and anti-angiogenic anti-FGFR1 single chain antibody 144
Fibroblast growth factor-2 in angiogenesis 143
Inflammatory cells and chemokines sustain FGF2-induced angiogenesis 140
Heparin derivatives as angiogenesis inhibitors 138
Osteopontin (Eta-1) and fibroblast growth factor-2 cross-talk in angiogenesis. 136
Osteopontin overexpression inhibits in vitro re-endothelialization via integrin engagement. 132
Modulation of fibroblast growth factor-2 receptor binding, signaling, and mitogenic activity by heparin-mimicking polysulfonated compounds 131
VEGFR2 activation mediates the pro-angiogenic activity of BMP4 130
Osteopontin overexpression inhibits in vitro re-endothelialization via integrin engagement 128
Role of inflammation in FGF2-driven angiogenesis 127
EXPLOTING SURFACE PLASMON RESONANCE (SPR) TECHNOLOGY FOR THE IDENTIFICATION OF FIBROBLAST GROWTH FACTOR-2 (FGF2) ANTAGONISTS ENDOWED WITH ANTI-ANGIOGENIC ACTIVITY 109
FGF2- Antagonist activity of long pentraxin-3 109
FGF2-Antagonist activity of long pentraxin-3 related peptides 107
Heparin derivatives and semysynthetic biotechnological heparins as angiogenesis inhibitors 106
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumor cells 103
Malnutrition Prevention after Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT): A Prospective Explorative Interventional Study with an Oral Polymeric Formulation Enriched with Transforming Growth Factor Beta 2 (TGF-β2) 102
THE CYSTINE-KNOT PROTEIN GREMLIN IS A NOVEL AGONIST OF THE MAJOR PRO-ANGIOGENIC RECEPTOR VEGFR2 101
Cutting Edge: IL-1beta Mediates the Proangiogenic Activity of Osteopontin-Activated Human Monocytes 96
Totale 5.667
Categoria #
all - tutte 22.241
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.241


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202142 0 0 0 0 0 0 0 0 0 0 0 42
2021/2022278 6 65 2 1 1 14 16 14 10 51 23 75
2022/2023253 37 11 23 14 14 54 0 26 31 2 20 21
2023/2024333 21 38 41 17 20 26 15 12 62 13 8 60
2024/2025682 16 11 7 85 62 58 72 52 81 33 110 95
2025/20261.436 142 156 103 180 238 95 252 33 66 113 47 11
Totale 5.667